Journal of Clinical Endocrinology & Metabolism, Vol 81, 852-856, Copyright © 1996 by Endocrine Society

ARTICLES

High levels of corticotropin-releasing factor (CRF) are inversely correlated with low levels of maternal CRF-binding protein in pregnant women with pregnancy-induced hypertension

F Petraglia, P Florio, C Benedetto, C Gallo, RJ Woods, AR Genazzani and PJ Lowry
Department of Gynecology and Obstetrics, Universities of Modena, Italy.

Corticotropin-releasing factor-binding protein (CRF-BP) is suggested to play a role in modulating the activity of the hypothalamus-pituitary- adrenal axis during pregnancy, counteracting the actions of circulating or locally acting CRF. The aim of the present study was to evaluate whether maternal levels of CRF-BP and CRF are modified in pregnant women with a high risk of developing pregnancy-induced hypertension (n = 21). A group of nine patients developed the disease between 25-35 weeks gestation, and sequential blood samples were taken every 5 weeks throughout the pregnancy. As a control group, healthy pregnant women were studied (n = 9) using the same protocol; a group of women with pregnancy-induced hypertension (n = 5) was studied starting from the time of diagnosis. In a subgroup of patients (n = 10), CRF-BP and CRF levels were studied after 5 weeks of antihypertensive treatment. Levels of CRF-BP were determined using a specific RIA, whereas CRF was evaluated by a two-site immunoradiometric assay. In patients at risk, circulating levels of CRF-BP followed the same pattern as that in healthy controls, showing a significant decrease at term (36-40 weeks; P < 0.05). A significant and progressive increase in plasma CRF levels was observed in both groups of pregnant women; the highest values were found at term (P < 0.01). In the nine patients who developed pregnancy- induced hypertension, maternal levels of CRF-BP at the onset of signs and symptoms were lower than control values, and CRF levels were significantly higher at the onset of the disease (P < 0.01). Similarly, in these hypertensive patients studied at the time of hospitalization, CRF-BP levels were lower whereas those of CRF were higher than levels in healthy patients (P < 0.01). No effect of antihypertensive therapy on either CRF-BP or CRF levels was observed. The present study shows an inverse correlation between reduced plasma CRF-BP levels and increased CRF levels in the maternal circulation of patients with pregnancy- induced hypertension, and indicates that these hormonal changes do not occur before the onset of disease, suggesting that the measurement of these polypeptides in maternal plasma does not predict the development of hypertension.

This article has been cited by other articles:

				P. Florio, R. Romero, T. Chaiworapongsa, J. P. Kusanovic, M. Torricelli, P. J. Lowry, and F. Petraglia Amniotic Fluid and Umbilical Cord Plasma Corticotropin-Releasing Factor (CRF), CRF-Binding Protein, Adrenocorticotropin, and Cortisol Concentrations in Intraamniotic Infection and Inflammation at Term J. Clin. Endocrinol. Metab., September 1, 2008; 93(9): 3604 - 3609. [Abstract] [Full Text] [PDF]

				P Florio, P J Lowry, C Benedetto, L Galleri, M Torricelli, A Giovannelli, R Battista, F M Reis, and F Petraglia Maternal plasma corticotropin-releasing factor (CRF) and CRF-binding protein (CRF-BP) levels in post-term pregnancy: effect of prostaglandin administration Eur. J. Endocrinol., September 1, 2007; 157(3): 279 - 284. [Abstract] [Full Text] [PDF]

				R. Sirianni, B. A. Mayhew, B. R. Carr, C. R. Parker Jr., and W. E. Rainey Corticotropin-Releasing Hormone (CRH) and Urocortin Act through Type 1 CRH Receptors to Stimulate Dehydroepiandrosterone Sulfate Production in Human Fetal Adrenal Cells J. Clin. Endocrinol. Metab., September 1, 2005; 90(9): 5393 - 5400. [Abstract] [Full Text] [PDF]

				P. Florio, A. Imperatore, F. Sanseverino, M. Torricelli, F. M. Reis, P. J. Lowry, and F. Petraglia The Measurement of Maternal Plasma Corticotropin-Releasing Factor (CRF) and CRF-Binding Protein Improves the Early Prediction of Preeclampsia J. Clin. Endocrinol. Metab., September 1, 2004; 89(9): 4673 - 4677. [Abstract] [Full Text] [PDF]

				P. Florio, L. Cobellis, J. Woodman, F. M. Severi, E. A. Linton, and F. Petraglia Levels of Maternal Plasma Corticotropin-Releasing Factor and Urocortin During Labor Reproductive Sciences, July 1, 2002; 9(4): 233 - 237. [Abstract] [PDF]

				F. M. Reis, D. D'Antona, and F. Petraglia Predictive Value of Hormone Measurements in Maternal and Fetal Complications of Pregnancy Endocr. Rev., April 1, 2002; 23(2): 230 - 257. [Abstract] [Full Text] [PDF]

				T.N. Leung, T. K.H. Chung, G. Madsen, C.W.K. Lam, P. K.W. Lam, W. A.W. Walters, and R. Smith Analysis of mid-trimester corticotrophin-releasing hormone and {alpha}-fetoprotein concentrations for predicting pre-eclampsia Hum. Reprod., August 1, 2000; 15(8): 1813 - 1818. [Abstract] [Full Text] [PDF]

				T. Simoncini, R. Apa, F. M. Reis, F. Miceli, M. Stomati, L. Driul, A. Lanzone, A. R. Genazzani, and F. Petraglia Human Umbilical Vein Endothelial Cells: A New Source and Potential Target for Corticotropin-Releasing Factor J. Clin. Endocrinol. Metab., August 1, 1999; 84(8): 2802 - 2806. [Abstract] [Full Text]

				F. M. Reis, M. Fadalti, P. Florio, and F. Petraglia Putative Role of Placental Corticotropin-Releasing Factor in the Mechanisms of Human Parturition Reproductive Sciences, May 1, 1999; 6(3): 109 - 119. [Abstract] [PDF]

				P. Florio, R. J. Woods, A. R. Genazzani, P. J. Lowry, and F. Petraglia Changes in Amniotic Fluid Immunoreactive Corticotropin-Releasing Factor (CRF) and CRF-Binding Protein Levels in Pregnant Women at Term and during Labor J. Clin. Endocrinol. Metab., March 1, 1997; 82(3): 835 - 838. [Abstract] [Full Text] [PDF]